GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Valiant Laboratories Ltd

Valiant Laboratories Reports Audited Q4 & Full Year FY26 Financial Results

RESULTS ▲ Positive Development LOW RISK
📅 Filed on BSE: 14 May 2026, 07:25 PM IST  ·  BSE ID: ed5a2e7b-c98c-45a5-9d19-e1479a3ac57e
View Original BSE Filing (PDF)
💡
In Simple Terms
The company released its official financial results for the last quarter and the full financial year, detailing its income and profits.
🤖 AI Summary
  • Board of Directors approved Audited Standalone and Consolidated Financial Results for Q4 and year ended March 31, 2026.
  • Standalone Revenue from Operations for Q4 FY26 was Rs. 6,530.34 Lakhs.
  • Standalone Net Profit for Q4 FY26 reported at Rs. 353.28 Lakhs.
  • Full year FY26 Standalone Revenue from Operations reached Rs. 21,704.25 Lakhs.
  • Full year FY26 Standalone Net Profit amounted to Rs. 554.82 Lakhs.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Standalone Revenue from Operations Q4 FY26
Rs. 6,530.34 Lakhs
13.04%
Standalone Net Profit Q4 FY26
Rs. 353.28 Lakhs
9.10%
Standalone Revenue from Operations FY26
Rs. 21,704.25 Lakhs
62.75%
Standalone Net Profit FY26
Rs. 554.82 Lakhs
Not comparable — limited prior period data.
Basic Earning per equity share FY26
Rs. 1.02
Not comparable — limited prior period data.
🏢 How This Affects the Company
📈
Business Impact
The financial results reflect the company's operational performance in its single segment of manufacturing chemicals, with an increase in revenue from operations for both the quarter and the full fiscal year.
💰
Financial Impact
The company reported a standalone net profit of Rs. 353.28 Lakhs for Q4 FY26 and Rs. 554.82 Lakhs for the full FY26, indicating positive earnings performance for the period.
👥 What This Means For Shareholders
✅
Action Required
No immediate action is required from shareholders based on this financial results filing.
👤
Who Is Affected
All shareholders are affected by the company's financial performance, as reflected by the standalone basic earnings per share of Rs. 1.02 for FY26.
🔍
Management Signal
The approval of audited results indicates management's adherence to regulatory compliance and transparent disclosure of financial performance.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Next quarterly results filing — check for sustained revenue and profit growth.
Any further disclosures regarding expansion or operational developments.
Annual Report publication — review detailed financial statements and outlook.
LOW RISK The filing reports positive financial results and adherence to audit processes.
💡 Investor Takeaway
Valiant Laboratories reported a standalone Net Profit of Rs. 353.28 Lakhs for Q4 FY26, up from Rs. 323.83 Lakhs in Q4 FY25. Full year FY26 standalone Net Profit was Rs. 554.82 Lakhs, a turnaround from a Net Loss of Rs. 215.02 Lakhs in FY25.
⚖️ Strengths & Concerns

✅ Positives

  • Standalone Revenue from Operations increased to Rs. 6,530.34 Lakhs in Q4 FY26 from Rs. 5,777.00 Lakhs in Q4 FY25.
  • Standalone Net Profit for the full year FY26 was Rs. 554.82 Lakhs, compared to a net loss of Rs. 215.02 Lakhs in FY25.

⚠️ Concerns

  • Standalone Other Income for the full year FY26 decreased to Rs. 289.48 Lakhs from Rs. 542.81 Lakhs in FY25.
  • Standalone Total Expenses for the full year FY26 increased to Rs. 21,238.94 Lakhs from Rs. 14,023.77 Lakhs in FY25.
📅 Company Track Record
Valiant Laboratories Limited was incorporated in 2021. The company recently listed via an IPO in September 2023. The Board had previously announced a meeting on May 14, 2026, to consider and approve FY26 results. The prior year's full financial data reflects a startup phase.

Based on publicly available historical data. For context only.

You've read one filing

There are 32,000 more, and one of them is about a company you own

Follow a company and we'll email you the moment it files again — explained, not just forwarded. Free.

  • Follow companies and get filings by email
  • Save any filing to read later
  • Two full AI analyses every month, free

No card needed. Sign in with Google in two taps.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.